Eikon Therapeutics, Inc. (EIKN)
9.43
-0.17
(-1.77%)
USD |
NASDAQ |
Jun 03, 16:00
9.475
+0.04
(+0.48%)
After-Hours: 19:59
Eikon Therapeutics Total Assets (Quarterly) : 850.83M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| MacroGenics, Inc. | 217.87M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Anika Therapeutics, Inc. | 179.39M |
| Savara, Inc. | 221.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 300.16M |
| Shareholders Equity (Quarterly) | 550.67M |
| Debt to Equity Ratio | 0.4628 |
| Current Ratio | 11.75 |